Sanofi produces partially-synthetic artemisinin in "large quantities" with Amyris pathway
April 18, 2013 | Analyst Insight
What They Said
Sanofi and the University of California, Berkeley, have announced production of the antimalarial drug artemisinin in large quantities for the first time. The compound was originally isolated from sweet...
Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.